In the field of immunotherapy, CDK1 expression is closely associated with immune cell infiltration patterns in the tumor microenvironment [32], and this finding provides a rationale for the development of novel therapeutic strategies based on immune checkpoint inhibitors. The gene discussed is CDK1; the disease is neoplasm.